序号 | 产品名称 | 产品数量 |
1 | GSK-3β inhibitor 3 | 1 |
2 | GSK-3βinhibitor 3 | 2 |
3 | RG-547 mesylate | 1 |
4 | RO-4584820 mesylate | 1 |
5 | R-547 mesylate | 1 |
6 | 6-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile | 1 |
7 | 1314134-92-3 | 1 |
8 | 六氢-3-(苯基甲基)吡咯并[1,2-A]吡嗪-1,4-二酮 | 1 |
9 | 1H-Indole-3-ethanamine,5-bromo-N,N-dimethyl-,hydrochloride | 1 |
10 | 2613384-12-4 | 1 |
11 | ACU-4429 hydrochloride | 1 |
12 | Emixustat hydrochloride | 1 |
13 | 3-(2-aminopropyl)phenol hydrochloride | 1 |
14 | 54779-56-5 | 1 |
15 | 3-phenoxy-8-azabicyclo[3.2.1]octane hydrochloride | 1 |
16 | 3-phenoxy-8-azabicyclo[3,2,1]octane hydrochloride | 1 |
17 | 1955540-15-4 | 1 |
18 | 2-(2-amino-3-methylbutanamido)-3-phenylpropanoic acid hydrochloride | 1 |
19 | 128090-87-9 | 1 |
20 | DRM-05 | 1 |
21 | QLT0074 | 1 |
22 | QLT 0074 | 1 |
23 | DRM05 | 1 |
24 | DRM 05 | 1 |
25 | QLT-0074 | 1 |
26 | Mereletinib (dimesylate) | 1 |
27 | AZD-9291 (dimesylate) | 1 |
28 | CP-45899-2 | 1 |
29 | IWP051 | 1 |
30 | CAY10563 | 2 |
31 | CAY10564 | 2 |
32 | GNF 1331 | 1 |
33 | 硫酸双肼屈嗪 | 2 |
34 | DU-717 | 1 |
35 | CP-690,550A | 1 |
36 | Tofacitinib metabolite M2 | 1 |
37 | UNII-Q7ZOK859UK | 1 |
38 | Racemic Tofacitinib | 1 |
39 | rac Tofacitinib | 1 |
40 | AGN-190342 | 1 |
41 | AGN 190342 | 1 |
42 | Bromoxidine | 1 |
43 | Betoptic | 1 |
44 | Kerlone | 1 |
45 | Apraclonidina | 1 |
46 | Iopidine | 1 |
47 | P-aminoclonidine | 1 |
48 | 4-Aminoclonidine | 1 |
49 | 377727-87-2 | 8 |
50 | Apraclonidinum | 1 |
51 | Apraclonidine hydrochloride | 1 |
52 | Peptide5 acetate | 1 |
53 | Phenol, 4-[2-(3,4-dimethoxyphenyl)ethyl]-2,6-dimethoxy- | 1 |
54 | 4-[2-(3,4-Dimethoxyphenyl)ethyl]-2,6-dimethoxyphenol | 1 |
55 | 鼓槌石斛素 | 1 |
56 | TGFβ-IN-2 | 1 |
57 | 2387678-02-4 | 1 |
58 | NTU281 | 1 |
59 | 815619-12-6 | 1 |
60 | TGFβ1-IN-1 | 1 |
61 | SMN2-Stablizer 27 | 1 |
62 | SMN2 Stablizer-27 | 1 |
63 | SMN2-Stablizer-27 | 1 |
64 | D-153249 | 1 |
65 | D 153249 | 1 |
66 | D153249 | 1 |
67 | 4-[2-(4-氟苯基)-5-(1-甲基-4-哌啶基)-1H-吡咯-3-基]吡啶 | 1 |
68 | Ro-23-7014 | 1 |
69 | CI951 | 1 |
70 | CI-951 | 1 |
71 | SB-201823-A | 1 |
72 | SB201823A | 1 |
73 | SARS-CoV-2-IN-14 | 1 |
74 | 22203-98-1 | 1 |
75 | SARS-CoV-2-IN-15 | 1 |
76 | 1580-42-3 | 1 |
77 | R6238 D4 | 1 |
78 | Apelin-36(rat, mouse) | 1 |
79 | Apelin-36 (rat, mouse) | 1 |
80 | Apelin-36 (human) | 1 |
81 | 2-NP-AMOZ | 1 |
82 | 183193-59-1 | 1 |
83 | Cytostatin (sodium salt) | 1 |
84 | HCI 2184 | 1 |
85 | HCI2184 | 1 |
86 | m-Topolin | 1 |
87 | 3-[(9H-嘌呤-6-基氨基)甲基]苯酚 | 2 |
88 | Isochiisanoside | 1 |
89 | 105591-35-3 | 1 |
90 | 人参皂苷Rs2 | 1 |
91 | Ginsenoside Rs2 | 1 |
92 | 87733-66-2 | 1 |
93 | 1-Formyl-β-carboline | 1 |
94 | 20127-63-3 | 1 |
95 | IdB-1028 | 1 |
96 | LF2646 | 1 |
97 | LF 2646 | 1 |
98 | Brakerin | 1 |
99 | IdB 1028 | 1 |
100 | LF-2646 | 1 |